Publication | Closed Access
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
104
Citations
36
References
2018
Year
Hematological MalignancyOncologyAmlsg 11-08 TrialImmunologyHematologyIntensive TreatmentMedicineCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1